Belgium became a donor to Gavi in 2020, making an initial contribution of €4 million (US$ 4.9 million) to the Gavi COVAX Advance Market Commitment (AMC), the global mechanism established to support equitable access to COVID-19 vaccines. This marked the beginning of Belgium’s partnership with Gavi and reflected its commitment to international solidarity and global vaccine equity.
Belgium subsequently expanded its support, providing an additional €8 million (US$ 9.1 million ) to the COVAX AMC in 2021 to support vaccine procurement and delivery. In 2022, Belgium contributed a further €2.3 million (US$ 2.5 million) for vaccine ancillary costs. In 2022, Belgium deepened its partnership with Gavi by contributing €3 million (US$ 3.2 million) to Gavi’s 2021–2025 strategic period, representing its first investment in Gavi’s core mission to protect children against vaccine-preventable diseases and strengthen immunisation systems. Belgium’s partnership with Gavi is underpinned by shared priorities on vaccine equity, global health security and sustainable development.
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: